Literature DB >> 14530656

Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan.

Kenjiro Kotake1, Satoshi Honjo, Kenichi Sugihara, Tomoyuki Kato, Susumu Kodaira, Takashi Takahashi, Masayuki Yasutomi, Tetsuichiro Muto, Yasuo Koyama.   

Abstract

PURPOSE: This study was designed to examine trends of colorectal cancer in relation to age, gender, site, and survival during the past 20 years.
METHODS: The multi-institutional registry of the Japanese Society for Cancer of the Colon and Rectum offered 87,695 surgical cases with invasive adenocarcinoma during 1978 to 1997 for analysis. We calculated survival rates and used the Cox's proportional hazard model for cases during 1978 to 1994.
RESULTS: The number of cases showed a 2.5-fold increase with consistent male predominance confined to the distal colon and the rectum. Colon cancer in the last five-year period was more likely right-sided for females (odds ratio, 1.26; 95 percent confidence interval, 1.16-1.38) and males (odds ratio, 1.16; 95 percent confidence interval, 1.06-1.25) compared with the first period. Cancers in younger patients were more likely at Stage III to IV in the late 1990s if the cancers were in the distal colon, the rectum (for both genders), or the proximal colon (for females). Survival was improved except for cases with proximal colon cancer of Stage IV. In the multivariate analysis, hazard ratios for death in the postoperative five years were 0.77, 0.59, and 0.66 for proximal colon, distal colon, and rectal cancers, respectively, in the last period as compared with those in the first period [corrected]. Reduced hazard ratio for females was the largest for proximal colon cancer with Stage I to II.
CONCLUSION: Although surgical outcome was largely improved, delayed presentation or diagnosis in younger patients remained a problem. Preferential localization in the proximal colon and survival benefit for females should be investigated.

Entities:  

Mesh:

Year:  2003        PMID: 14530656     DOI: 10.1097/01.DCR.0000083389.92214.AA

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  34 in total

1.  Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients.

Authors:  Seiya Saito; Naoko Hayashi; Nobutaka Sato; Masaaki Iwatsuki; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Masayuki Watanabe; Minoru Yoshida; Kenji Sakai; Takashi Katsumori; Shigeru Katahuchi; Nobuyuki Shigaki; Kazutaka Yamada; Masami Kimura; Tomio Tanigawa; Sadamu Takano; Masafumi Kuramoto; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2012-06-05       Impact factor: 3.402

2.  Surgery for colorectal cancer in a low-volume unit: assessment of key issues in the achievement of acceptable clinical results.

Authors:  Hannu Paimela; Outi Lindström; Timo Tomminen; Mauri Iivonen; Esa Könönen; Pekka Kuusanmäki
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Site distribution of gastrointestinal carcinoids differs between races.

Authors:  T Konishi; T Watanabe; T Muto; K Kotake; H Nagawa
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

4.  Utility of single balloon enteroscopy (SBE) for difficult cases of total colonoscopy.

Authors:  Yoshinori Arai; Tomohiro Kato; Seiji Arihiro; Munenori Itagaki; Nobuhiko Komoike; Isao Odagi; Masayuki Saruta; Mika Matsuoka; Takeshi Suzuki; Hisao Tajiri
Journal:  J Interv Gastroenterol       Date:  2012-01-01

5.  Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database.

Authors:  Hirotoshi Kobayashi; Hiroaki Miyata; Mitsukazu Gotoh; Hideo Baba; Wataru Kimura; Yuko Kitagawa; Tohru Nakagoe; Mitsuo Shimada; Naohiro Tomita; Kenichi Sugihara; Masaki Mori
Journal:  J Gastroenterol       Date:  2013-07-27       Impact factor: 7.527

6.  Gender differences in colorectal cancer survival in Japan.

Authors:  Kenjiro Kotake; Michio Asano; Heita Ozawa; Hirotoshi Kobayashi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

7.  Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.

Authors:  Tomohisa Furuhata; Kenji Okita; Toshihiko Nishidate; Koichi Hirata; Hirofumi Ohnishi; Hirotoshi Kobayashi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-03-12       Impact factor: 3.402

8.  Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.

Authors:  Nozomu Machida; Kouji Yoshizaki; Narikazu Boku; Kentaro Yamazaki; Yusuke Onozawa; Akira Fukutomi; Hirofumi Yasui; Keisei Taku
Journal:  Int J Clin Oncol       Date:  2012-02-25       Impact factor: 3.402

9.  Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2012-02-28       Impact factor: 3.402

10.  Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer.

Authors:  Yasutake Uchima; Takafumi Nishii; Yasuhito Iseki; Mariko Ishii; Soichiro Hiramatsu; Takehiko Iwauchi; Junya Morimoto; Kinshi Kosaka; Seika Tei; Kazuhiro Takeuchi
Journal:  Mol Clin Oncol       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.